ModivCare Inc has a consensus price target of $44.8, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, Barrington Research, and Jefferies on May 6, 2024, February 26, 2024, and February 23, 2024. With an average price target of $29.67 between Lake Street, Barrington Research, and Jefferies, there's an implied 9.35% upside for ModivCare Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/06/2024 | Buy Now | 84.3% | Lake Street | Brooks O'Neil | → $50 | Upgrade | Hold → Buy | Get Alert |
02/26/2024 | Buy Now | — | Barrington Research | Michael Petusky | — | Downgrade | Outperform → Market Perform | Get Alert |
02/23/2024 | Buy Now | 43.75% | Jefferies | Brian Tanquilut | $60 → $39 | Downgrade | Buy → Hold | Get Alert |
02/23/2024 | Buy Now | 47.44% | Deutsche Bank | Pito Chickering | $60 → $40 | Downgrade | Buy → Hold | Get Alert |
11/06/2023 | Buy Now | 150.65% | Barrington Research | Michael Petusky | $58 → $68 | Maintains | Outperform | Get Alert |
08/07/2023 | Buy Now | 113.79% | Barrington Research | Michael Petusky | $92 → $58 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2023 | Buy Now | 84.3% | Deutsche Bank | Pito Chickering | $75 → $50 | Maintains | Buy | Get Alert |
06/27/2023 | Buy Now | 250.17% | Stephens & Co. | Scott Fidel | → $95 | Reiterates | Overweight → Overweight | Get Alert |
06/06/2023 | Buy Now | 250.17% | Stephens & Co. | Scott Fidel | → $95 | Reiterates | Overweight → Overweight | Get Alert |
05/05/2023 | Buy Now | 239.11% | Barrington Research | Michael Petusky | $143 → $92 | Maintains | Outperform | Get Alert |
05/05/2023 | Buy Now | 250.17% | Stephens & Co. | Scott Fidel | $145 → $95 | Maintains | Overweight | Get Alert |
02/24/2023 | Buy Now | 342.31% | Deutsche Bank | Pito Chickering | $100 → $120 | Maintains | Buy | Get Alert |
02/24/2023 | Buy Now | 427.09% | Barrington Research | Michael Petusky | $138 → $143 | Maintains | Outperform | Get Alert |
11/04/2022 | Buy Now | 408.66% | Barrington Research | Michael Petusky | $157 → $138 | Maintains | Outperform | Get Alert |
08/03/2022 | Buy Now | 434.46% | Stephens & Co. | Scott Fidel | → $145 | Initiates | → Overweight | Get Alert |
02/03/2022 | Buy Now | 452.89% | Deutsche Bank | Pito Chickering | $180 → $150 | Maintains | Buy | Get Alert |
12/17/2021 | Buy Now | 563.47% | Deutsche Bank | Pito Chickering | — | Initiates | → Buy | Get Alert |
The latest price target for ModivCare (NASDAQ: MODV) was reported by Lake Street on May 6, 2024. The analyst firm set a price target for $50.00 expecting MODV to rise to within 12 months (a possible 84.30% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for ModivCare (NASDAQ: MODV) was provided by Lake Street, and ModivCare upgraded their buy rating.
The last upgrade for ModivCare Inc happened on May 6, 2024 when Lake Street raised their price target to $50. Lake Street previously had a hold for ModivCare Inc.
The last downgrade for ModivCare Inc happened on February 26, 2024 when Barrington Research changed their price target from N/A to N/A for ModivCare Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ModivCare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ModivCare was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
While ratings are subjective and will change, the latest ModivCare (MODV) rating was a upgraded with a price target of $0.00 to $50.00. The current price ModivCare (MODV) is trading at is $27.13, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.